A total of 64 products will face rebates for inflationary price increases in the US Medicare Part B program during the first year of new penalty for manufacturers whose price increases have outpaced background rates of inflation.
The White House highlighted that number in announcing the latest update to the list of drugs in the physician-administered payment...








